Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Not yet recruiting × Biological Products × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Unknown 2 Terminated 2 Recruiting 1 Not yet recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 1

Interventions

Cyclophosphamide 19 fludarabine 14 pembrolizumab 12 Specimen Handling 11 Nivolumab 11 Magnetic Resonance Spectroscopy 9 Cisplatin 8 tislelizumab 6 Radiotherapy 6 Carboplatin 6 Interleukin-2 5 venetoclax 4 daratumumab 4 Rituximab 4 Radiosurgery 4 Ipilimumab 4 Injections 4 Fluorouracil 4 Drug Therapy 4 Doxorubicin 4 Docetaxel 4 Dexamethasone 4 Biopsy 4 Azacitidine 4 toripalimab 3 fludarabine phosphate 3 durvalumab 3 X-Rays 3 Vincristine 3 Stem Cell Transplantation 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07366658 2026-01-26

NEUK203-13

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 1 Not yet recruiting

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡